Cancer is a disease that has been on the epidemic rise in the last few years, and as per reports around forty percent of United States’ population would suffer some form of cancer during their lifetime. In 2014 alone, there were around 14.5 million U.S. citizens battling cancer. In the next ten years, the figure is expected to reach around twenty million. However, thanks to many technological advances being made in the medical field, many forms of cancer are now recoverable. Moreover, availability and centralization of cancer therapies related data are now possible with the help of efforts made by Tempus; a data centric technology firm co-founded by Eric Lefkofksy. As a noted and successful entrepreneur with plenty of resources to his disposable, Eric Lefkofsky is leaving no stone unturned in ensuring that Tempus can meet its objectives.
Eric Lefkofsky does not have a medical background, and his focus was never to start a company in the medical world until his wife was diagnosed with breast cancer. During the diagnosis of his wife, Eric Lefkofsky realized that there is a significant lack of the availability of cancer treatment related data that would help the oncologists to pinpoint which cancer therapy would be more efficient. It is often seen that some form of therapy is effective on some patient while being completely ineffective on others. Many factors go into play including genomics and the medical history of the patient when deciding upon which cancer treatment to follow for a particular patient. It is what Tempus helps in determining through the data enabled precision medicine. The availability of such data can potentially save lives.
Tempus takes into account the molecular as well as clinical data of the patient and correlates it with the thousands of electronic health records collected from different hospitals and cancer treatment facilities. It helps in coming to a conclusion as to which cancer treatment and medicine would be beneficial for the patient. It reduces the confusion among the oncologists in complicated cases and makes cancer treatment more effective overall. Tempus has also reduced the need for the doctors to follow one size fits all approach when it comes to cancer treatment as each patient is different.
To know more visit @: www.lightbank.com/team/eric-lefkofsky